Oxytocin Attenuates Neural Reactivity to Masked Threat Cues from the Eyes

Neuropsychopharmacology

Volumn 40, Issue 2, 2015, Pages 287-295

  Kanat, Manuela ^a,b   Heinrichs, Markus ^a,b   Schwarzwald, Ralf ^b   Domes, Gregor ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN;

ADULT; ASSOCIATION; ATTENTION; BRAIN; BRAIN MAPPING; DRUG EFFECTS; EYE; FACIAL EXPRESSION; FACIAL RECOGNITION; HEMISPHERIC DOMINANCE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MALE; MOUTH; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOSTIMULATION; PHYSIOLOGY; YOUNG ADULT;

ADMINISTRATION, INTRANASAL; ADULT; ATTENTION; BRAIN; BRAIN MAPPING; CUES; EYE; FACIAL EXPRESSION; FACIAL RECOGNITION; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MOUTH; NEUROPSYCHOLOGICAL TESTS; OXYTOCIN; PHOTIC STIMULATION; YOUNG ADULT;

EID: 84937644270     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.183     Document Type: Article

References (48)

1. Adolphs R 2008 Fear, faces, and the human amygdale Curr Opin Neurobiol 18 166-172.
2. Adolphs R, Gosselin F, Buchanan TW, Tranel D, Schyns P, Damasio AR (2005). A mechanism for impaired fear recognition after amygdala damage. Nature 433: 68-72.
3. Bate S, Cook SJ, Duchaine B, Tree JJ, Burns EJ, Hodgson TL (2014). Intranasal inhalation of oxytocin improves face processing in developmental prosopagnosia. Cortex 50: 55-63.
4. Bertsch K, Gamer M, Schmidt B, Schmidinger I, Walther S, Kästel T et al (201 3). Oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder. Am J Psychiatry 170: 1169-1177.
5. Bethlehem RAI, Honk J, Van Auyeung B, Baron-Cohen S (2013). O xytocin, brain physiology, and functional connectivity: A review of intranasal oxytocin fMRI studies. Psychoneuroendocrinology 38: 962-974.
6. Domes G, Heinrichs M, Glascher J, Büchel C, Braus DF, Herpert z SC (2007). Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry 62: 1187-1190.
7. Domes G, Heinrichs M, Kumbier E, Grossmann A, Hauenstein K, Herpertz SC (2013a). Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder. Biol Psychiatry 74: 164-171.
8. Domes G, Kumbier E, Heinrichs M, Herpertz SC (2014). Oxytocin promotes facial emotion recognition and amygdala reactivity in adults with Asperger syndrome. Neuropsychopharmacology 39: 698-706.
9. Domes G, Sibold M, Schulze L, Lischke A, Herpertz SC, Heinrichs M (2013 b). Intranasal oxytocin increases covert attention to positive social cues. Psychol Med 43: 1747-1753.
10. Domes G, Steiner A, Porges SW, Heinrichs M (2013c). Oxytocin differentially modulates eye gaze to naturalistic social signals of happiness and anger. Psychoneuroendocrinology 38: 1198-1202.
11. Eisenbarth H, Alpers GW (2011). Happy mouth and sad eyes: Scanning emotional facial expressions. Emotion 11: 860-865.
12. Ellenbogen MA, Linnen AM, Grumet R, Cardoso C, Joober R (2012). The acute effects of intranasal oxytocin on automatic and effortful attentional shifting to emotional faces. Psychophysiology 49: 128-137.
13. Evans AC, Collins DL, Mills SR, Brown ED, Kelly RL, Peters TM (1993). 3D statistical neuroanatomical models from 305 MRI volumes. Nuclear Sci Symp Med Imaging Confc 3: 1813-1817.
14. Friston KJ, Buechel C, Fink GR, Morris J, Rolls E, Dolan RJ (1997). Psychophysiological and modulatory interactions in neuroimaging. NeuroImage 6: 218-229.
15. Gamer M, Zurowski B, Buchel C (2010). Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans. Proc Natl Acad Sci USA 107: 9400-9405.
16. Gläscher J (2009). Visualization of group inference data in functional neuroimaging. Neuroinformatics 7: 73-82.
17. Gordon I, Wyk BCV, Bennett RH, Cordeaux C, Lucas MV, Eilbott JA et al (2013). Oxytocin enhances brain function in children with autism. Proc Natl Acad Sci USA 110: 20953-20958.
18. Guastella AJ, Carson DS, Dadds MR, Mitchell PB, Cox RE (2009). Does oxytocin influence the early detection of angry and happy faces? Psychoneuroendocrinology 34: 220-225.
19. Heinrichs M, Dawans B, von Domes G (2009). Oxytocin, vasopressin, and human social behavior. Front Neuroendocrinol 30: 548-557.
20. Heinrichs M, Domes G (2008). Neuropeptides and social behaviour: Effects of oxytocin and vasopressin in humans. Prog Brain Res 170: 337-350.
21. Horley K, Williams LM, Gonsalvez C, Gordon E (20 03). Social phobics do not see eye to eye: A visual scanpath study of emotional expression processing. J Anxiety Disord 17: 33-44.
22. Hurlemann R, Patin A, Onur OA, Cohen MX, Baumgartner T, Metzler S et al (2010). Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. J Neurosci 30: 4999-5007.
23. Kanat M Heinrichs M Domes G(2013). Oxytocin and the social brain: Neural mechanisms and perspectives in human research. Brain Res; e-pub ahead of print 8 November 2013; doi:10.1016/j.brainres.2013.11.003.
24. Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S et al (2005). Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 25: 11489-11493.
25. Kliemann D, Dziobek I, Hatri A, Steimke R, Heekeren HR (2010). Atypical reflexive gaze patterns on emotional faces in autism spectrum disorders. J Neurosci 30: 12281-12287.
26. Leknes S, Wessberg J, Ellingsen D-M, Chelnokova O, Olausson H, Laeng B (2013). Oxytocin enhances pupil dilation and sensitivity to ?hidden' emotional expressions. Soc Cogn Affect Neurosci 8: 741-749.
27. Liddell BJ, Brown KJ, Kemp AH, Barton MJ, Das P, Peduto A et al (2005). A direct brainstem-amygdala-cortical ?alarm' system for subliminal signals of fear. NeuroImage 24: 235-243.
28. Liddel l BJ, Williams LM, Rathjen J, Shevrin H, Gordon E (2004). A temporal dissociation of subliminal versus supraliminal fear perception: An event-related potential study. J Cogn Neurosci 16: 479-486.
29. Li schke A, Berger C, Prehn K, Heinrichs M, Herpertz SC, Domes G (2012). Intranasal oxytocin enhances emotion recognition from dynamic facial expressions and leaves eye-gaze unaffected. Psychoneuroendocrinology 37: 4 75-481.
30. Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M (2011). Oxytocin and vasopressin in the human brain: Social neuropeptides for translational medicine. Nat Rev Neurosci 12: 524-538.
31. Miyahara M, Harada T, Ruffman T, Sadato N, Iidaka T (2013). Functional connectivity between amygdala and facial regions involved in recognition of facial threat. Soc Cogn Affect Neurosci 8: 181-189.
32. Nor man GJ, Cacioppo JT, Morris JS, Karelina K, Malarkey WB, DeVries AC et al (2011). Selective influences of oxytocin on the evaluative processing of social stimuli. J Psychopharmacol 25: 1313-1319.
33. Pessoa L, Adolphs R (2010). Emotion processing and the amygdala: From a ?low road' to ?many roads' of evaluating biological significance. Nat Rev Neurosci 11: 773-783.
34. Petrovic P, Kalisch R, Singer T, Dolan RJ (2008). Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci 28: 6607-6615.
35. Prehn K, Kazzer P, Lischke A, Heinrichs M, Herpertz SC, Domes G (2013). Effects of intranasal oxytocin on pupil dilation indicate increased salience of socioaffective stimuli. Psychophysiology 50: 528-537.
36. Scheller E, Bu?chel C, Gamer M (2012). Diagnostic features of emotional expressions are processed preferentially. PLoS ONE 7: E41792.
37. Schulze L, Lischke A, Greif J, Herpertz SC, Heinrichs M, Domes G (2011). Oxytocin increases recognition of masked emotional faces. Psychoneuroendocrinology 36: 1378-1382.
38. Shahrestani S, Kemp AH, Guastella AJ (2013). The impact of a single administration of intranasal oxytocin on the recognition of basic emotions in humans: A meta-analysis. Neuropsychopharmacology 38: 1929-1936.
39. Smith ML, Cottrell GW, Gosselin F, Schyns PG (2005). Transmitting and decoding facial expressions. Psychol Sci 16: 184-189.
40. Steyer R, Schwenkmezger P, Notz P, Eid M (1997). Der Mehrdimensionale Befindlichkeitsfragebogen MDBF [Multidimensional Mood Questionnaire]. Hogrefe: Göttingen, Germany.
41. Streit M, Dammers J, Simsek-Kraues S, Brinkmeyer J, Wo?lwer W, Ioannides A (2003). Time course of regional brain activations during facial emotion recognition in humans. Neurosci Lett 342: 101-104.
42. Tamietto M, De Gelder B (2010). Neural bases of the non-conscious perception of emotional signals. Nat Rev Neurosci 11: 697-709.
43. Tollenaar MS, Chatzimanoli M, Wee NJA, Van der, Putman P (2013). Enhanced orienting of attention in response to emotional gaze cues after oxytocin administration in healthy young men. Psychoneuroendocrinology 38: 1797-1802.
44. Tottenham N Tanaka JW Leon AC McCarry T Nurse M Hare TA et al. 2009 The NimStim set of facial expressions: Judgments from untrained research participants.Psychiatry Res 168 242-249.
45. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N et al (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 15: 273-289.
46. Whalen PJ, Rauch SL, Etcoff NL, McInerney SC, Lee MB, Jenike MA (1998). Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neurosci 18: 411-418.
47. Wittchen H-U, Zaudif M, Fydrich T (1997). Strukturiertes klinisches Interview für DSM-IV [Structured Clinical Interview for DSM-IV]. Hogrefe: Göttingen.
48. Zaitsev M, Hennig J, Speck O (2004). Point spread function mapping with parallel imaging techniques and high acceleration factors: FAST, ROBUSt, and flexible method for echoplanar imaging distortion correction. Magn Reson Med 52: 1156-1166.